# A Study of KHK4827 in Patients With Systemic Sclerosis

> **NCT04368403** · PHASE1 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 8 (actual)

## Conditions studied

- Systemic Sclerosis

## Interventions

- **DRUG:** KHK4827

## Key facts

- **NCT ID:** NCT04368403
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-06
- **Primary completion:** 2019-01-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04368403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04368403, "A Study of KHK4827 in Patients With Systemic Sclerosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04368403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*